SPONSORED POST

By BAYER G4A

Digital health is changing the world

From chronic disease management to prevention, G4A’s goal is to empower people with the tools and access they need to take control of their health. G4A does this through fostering a diverse and vibrant ecosystem of digital health partners to support their growth and impact.

On April 20th, G4A launched its 2020 Partnership Program with an open call for applications. The aim of the Partnerships Program is to work with companies across the globe on healthcare’s toughest challenges and innovate together towards a future of integrated care. This year G4A is seeking to collaborate with companies that are making an impact in the following areas:

• Cardiometabolic and Renal Diseases – Heart health requires a 360-approach that encompasses lifestyle behaviors, remote monitoring, biomarker review, risk stratification, and more
• Oncology – Utilizing targeted therapies and patient performance technologies can identify patients efficiently and slow disease progression
• Women’s Health – Novel approaches are needed to manage gynecological conditions such as PCOS and Endometriosis, as well as Menopause, and provide answers to the unique needs of women’s health
• Pharmacovigilance – The opportunity for innovation in drug safety is huge, specifically as it relates to adverse event detection

G4A’s 2020 Partnership Program offers two tracks for participation. The Growth Track is designed for early stage companies (Seed-Series A) while the Advance Track is for companies that are more mature and already have traction in the market with a product or service. Selected partners will expand their reach and provide valuable solutions in healthcare together with Bayer G4A’s guidance. Together, we can change the experience of health.

Applications are now open till June 30th, 11:59 CET. More information about G4A’s challenges on: https://www.g4a.health/partnerships.

Since its launch in 2013, Bayer has supported over 150 digital health companies resulting in more than 30 direct collaborations. Bayer now operates G4A in more than 13 countries, developing and promoting collaborative health care technology projects around the world.